المؤلفون: J. Verloop, Adri C. Voogd, Paula H.M. Elkhuizen, Philip Poortmans, Liesbeth J. Boersma, A. Elise van Leeuwen, Ruud Houben, Sabine C. Linn, Ruud M. Pijnappel, Jelle Wesseling, Thijs van Dalen, Luc J. A. Strobbe, Linda de Munck

المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Radiotherapie, Epidemiologie

المصدر: Radiotherapy and Oncology, 145, 201-208. Elsevier Ireland Ltd

مصطلحات موضوعية: Oncology, medicine.medical_specialty, POSTMASTECTOMY RADIOTHERAPY, medicine.medical_treatment, Planning target volume, Breast Neoplasms, Systemic therapy, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, NEOADJUVANT CHEMOTHERAPY, 0302 clinical medicine, Breast cancer, Internal medicine, MASTECTOMY, medicine, Humans, Radiology, Nuclear Medicine and imaging, Primary chemotherapy, Prospective Studies, CANCER PATIENTS, LOCOREGIONAL RECURRENCE, Prospective cohort study, SURGICAL ADJUVANT BREAST, Neoplasm Staging, Netherlands, business.industry, INDIVIDUAL PATIENT DATA, INTERNAL MAMMARY, PREOPERATIVE CHEMOTHERAPY, Hematology, medicine.disease, Current analysis, Radiation therapy, Lymphatic Metastasis, 030220 oncology & carcinogenesis, AXILLARY DISSECTION, Radiotherapy, Adjuvant, business, Mastectomy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3869464fc6d9ef487ddd4f8d222ef1ce
https://doi.org/10.1016/j.radonc.2020.01.018